Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma [Phase 2]
Phase 2 study evaluating neoadjuvant adebrelimab plus etoposide and cisplatin for neuroendocrine carcinoma of the bladder, with recruitment …
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Clinical trial update reporting ctDNA findings in patients with muscle-invasive bladder cancer treated with trimodality therapy.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
This clinical trial completed development of a multiphasic CT-based delta-radiomics model to predict postoperative recurrence risk in bladde…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) [NA]
Clinical trial update indicates Medtronic's Hugo Robotic Assisted Surgery System is being evaluated in urologic surgeries across several con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] [Phase 2]
This clinical trial update describes a Phase 2 study evaluating pembrolizumab plus Bacillus Calmette-Guérin as first-line therapy for high-r…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Results from the CISTO trial compare intravesical therapy with surgical options as treatments for bladder cancer. The study includes non-mus…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Avelumab and Radiation in Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating avelumab with radiation for muscle-invasive bladder cancer was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
Clinical trial INSITE investigates pre-surgical identification of muscle-invasive tumor involvement in patients with urothelial carcinoma sc…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer [NA]
A Phase II trial evaluating an organ-conserving radiochemotherapy approach for muscle-invasive bladder cancer has been terminated, with resu…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder [Phase 2]
Phase 2 trial of docetaxel in combination with lapatinib for metastatic transitional cell carcinoma of the bladder was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer [Phase 2]
Phase 2 window-of-opportunity trial evaluating pembrolizumab alone and in combinations in bladder cancer; results were posted on 2025-10-07.
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer [Phase 3]
Phase 3 trial evaluating perioperative chemotherapy for locally advanced bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors [Phase 2]
This document provides an update on the Phase 2 trial of pemigatinib in non-muscle invasive bladder cancer patients with recurrent low- or i…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
A clinical trial evaluating a urine DEK ELISA for diagnosing bladder cancer was terminated. The document does not provide efficacy results.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Use of Wearables Following Cystectomy- Part II [NA]
Enrollment update for Part II of a study evaluating wearables after cystectomy in patients with bladder cancer or neurogenic bladder disorde…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer; re…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of ESG401 in Adults With Solid Tumors [Phase 1, Phase 2]
Clinical trial update on ESG401 in adults with solid tumors, spanning Phase 1 and Phase 2. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating dietary fiber during radiotherapy in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a CAR-T cell therapy for bladder cancer (urothelial carcinoma of the bladder) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab [Phase 2]
This is a Phase 2 trial evaluating trilaciclib in combination with chemotherapy followed by avelumab for advanced/metastatic urothelial carc…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer [Phase 2]
A Phase 2 trial of immunotherapy with or without radiation therapy for metastatic urothelial carcinoma, including platinum-resistant disease…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients [Phase 1]
A Phase 1 clinical trial is investigating whether Vitamin B3 can enhance immunotherapy in patients with bladder cancer, with the study curre…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
The DELFI-L101 study from Delfi Diagnostics, which evaluates DNA fragment analysis for early interception of cancer, has completed enrollmen…